Menopause and Mental Health: What's Real, What's Myth, What Helps

Answer first: Perimenopause can coincide with new or worsening low mood, anxiety, poor sleep, and problems with concentration or memory. These symptoms are real, but they are not inevitable, and menopause does not cause depression in most women. The right plan separates menopause-related symptoms from a depressive or anxiety disorder, sleep disorder, medication effect, and medical mimics. Treatment may include psychological therapy, practical lifestyle measures, treatment of disruptive physical symptoms, medication for a diagnosed mental-health condition, and individualised menopausal hormone therapy when appropriate.

Educational disclaimer: This article provides general information. It cannot diagnose the cause of your symptoms or replace individual assessment by a qualified healthcare professional. Dr. Dina Rezk Clinic provides gynaecology and women's-health consultation. It does not provide psychiatry, psychology, therapy, counselling, mental-health medication management, or emergency care.

Key takeaways

• Perimenopause and menopause are not the same point in time. Perimenopause is the transition leading up to menopause. Menopause is confirmed after 12 consecutive months without a menstrual period when there is no other cause (WHO).
• Low mood, anxiety, poor sleep, and “brain fog” can occur during perimenopause. A 2024 meta-analysis found higher odds of depressive symptoms or diagnoses in perimenopause than before menopause, but it did not find a significant increase after menopause (Badawy et al., 2024).
• Symptoms should not automatically be blamed on hormones. Depression, anxiety disorders, thyroid disease, iron deficiency anaemia, sleep disorders, medicine effects, and difficult life circumstances can look similar or overlap.
• NICE recommends considering menopausal hormone therapy, or MHT, for depressive symptoms that begin around the same time as other menopause symptoms and do not meet criteria for depression. MHT is not a stand-alone treatment for diagnosed depression (NICE NG23).
• Cognitive symptoms are usually described as forgetfulness, slower recall, or difficulty concentrating. They deserve assessment when they are progressive, unusual for you, disabling, or accompanied by neurological signs.
• Suicidal intent, inability to stay safe, psychosis, severe confusion, or an acute neurological or medical problem needs immediate help.

Perimenopause vs menopause: what do the terms mean?

Perimenopause is the transition from the first features of reproductive ageing until one year after the final menstrual period. Menopause is confirmed retrospectively after 12 consecutive months without menstruation when pregnancy, medication, or another condition does not explain the change. Postmenopause is the time after that point.

The World Health Organization says most women experience natural menopause between ages 45 and 55. The transition may begin with a changed cycle, but there is no single sequence. Periods can become shorter, longer, lighter, heavier, closer together, or more widely spaced before they stop.

This distinction matters for mental health because the period of fluctuation may be more relevant than the final menstrual period itself. A 2024 systematic review and meta-analysis found that perimenopausal women had higher odds of depressive symptoms and diagnoses than premenopausal women. It did not find a significant increase for postmenopausal women compared with premenopausal women. The studies used different staging and depression measures, so the result describes a population pattern, not an individual forecast.

NICE calls menopause between 40 and 44 early menopause. Menopause before 40 raises the possibility of premature ovarian insufficiency and needs medical assessment because health and treatment considerations differ (NICE NG23). Menopause after surgery or treatment can also feel different because the hormonal change may be abrupt.

Pregnancy remains possible during perimenopause. WHO advises contraception until 12 consecutive months without menstruation, although individual advice depends on age, health, and the method used (WHO). MHT is not contraception.

What is real about menopause and mental health?

The Royal College of Psychiatrists' 2026 position statement says perimenopausal hormonal change is commonly associated with low mood, anxiety, poor sleep, and brain fog. For some women, symptoms may worsen an existing mental disorder or coincide with a first episode. The statement advises clinicians to consider perimenopause or menopause in new psychiatric, cognitive, or behavioural presentations between ages 35 and 55.

Hormones do not act alone. Hot flushes can interrupt sleep, poor sleep can affect mood and concentration, and heavy bleeding can contribute to iron deficiency. Life pressures may remove recovery time. The useful model is an interaction, not a single switch.

Badawy and colleagues pooled prospective cohort evidence and reported an odds ratio of 1.40 for depressive symptoms or diagnoses in perimenopause compared with premenopause (Badawy et al., 2024). This does not mean 40% of women become depressed. It compares group odds and does not give one woman's absolute risk.

It is also real that some women pass through the transition with few psychological symptoms. Others experience distress that is substantial but does not meet criteria for a mental disorder. A smaller group develops depression, an anxiety disorder, or worsening of a previous condition and needs condition-specific care. None of these paths reflects strength or character.

Mood, anxiety, sleep, and cognition are different problems

“I don't feel like myself” is a useful starting sentence, but assessment needs to unpack it. Four symptom groups often overlap while pointing to different next steps.

Mood is more than irritability

Brief frustration or tearfulness can accompany poor sleep. Depression is broader, usually involving persistent low mood or loss of interest with changes in energy, sleep, appetite, thinking, self-worth, or hope. Pattern, duration, severity, and impairment matter.

Anxiety can appear for the first time

Some women report new agitation, panic-like episodes, or a stronger reaction to uncertainty. Assessment matters if anxiety persists, is hard to control, or narrows daily life. Palpitations and sweating may reflect anxiety, hot flushes, thyroid disease, medicine effects, or a heart rhythm problem.

For a full discussion of anxiety disorders and treatment, use the anxiety in women guide. This page focuses on the menopausal window rather than repeating the anxiety treatment ladder.

Sleep can drive daytime symptoms

Broken nights can affect patience and concentration. Night sweats may begin the disruption, but worry about sleep can later maintain it. Snoring, breathing pauses, choking, uncomfortable leg sensations, or dangerous daytime sleepiness suggest a sleep disorder rather than “menopause insomnia.”

The sleep problems in women guide covers insomnia, sleep apnoea, restless legs, and CBT-I in depth. Here, the key point is diagnostic: improving sleep may improve mood and concentration, but severe daytime depression or anxiety should not be reduced to a sleep complaint.

Brain fog is not automatically dementia

Menopause-related cognitive complaints often involve slower retrieval, distractibility, or difficulty holding several tasks in mind. Poor sleep, anxiety, hot flushes, stress, depression, medication, thyroid disease, and nutritional deficiency can contribute.

Brain fog should not be used as a blanket explanation for progressive decline. Getting lost in familiar places, losing the ability to perform familiar tasks, marked personality change, new weakness, facial droop, speech disturbance, or a sudden severe headache needs medical assessment. Sudden neurological symptoms are urgent.

Ordinary distress or a clinical disorder?

A difficult transition is not automatically a psychiatric disorder. Assessment becomes more important when symptoms persist, recur, cause marked distress, impair function, create safety concerns, or meet the wider pattern of depression, an anxiety disorder, bipolar disorder, psychosis, or another condition.

Ordinary distress may follow a night of sweating, an unpredictable period, a frightening news story about menopause, or a week of too many demands. You may feel irritable or foggy but still recognise pleasure, recover after rest, and function with adjustments.

Seek a fuller assessment when you notice one or more of these changes:

• low mood or loss of interest on most days rather than only after a poor night;
• anxiety that feels difficult to control, leads to panic, or changes where you go and what you do;
• sleep disruption with substantial daytime impairment;
• concentration problems that interfere with work, medication safety, driving, finances, or familiar tasks;
• marked agitation, unusually elevated energy, much less need for sleep, impulsive behaviour, or racing ideas;
• increased alcohol, sedative, stimulant, or substance use to cope;
• thoughts that life is not worth living, thoughts of self-harm, or fear that you cannot stay safe.

NICE depression guidance asks clinicians to consider symptoms, duration, previous history, functional impairment, and personal circumstances rather than relying only on a symptom count (NICE NG222). A questionnaire may support an assessment, but it cannot decide by itself whether symptoms are menopause-related distress, depression, or both.

Who is more likely to struggle?

Risk is not destiny, and no checklist predicts an individual outcome. These factors make a more careful conversation worthwhile:

• a previous episode of depression, anxiety, bipolar disorder, psychosis, or severe reproductive-stage mood symptoms;
• symptoms emerging alongside disruptive hot flushes, night sweats, or prolonged poor sleep;
• early, premature, surgical, or treatment-induced menopause, especially when the change is unexpected;
• major illness, chronic pain, bereavement, caregiving pressure, relationship strain, work stress, financial pressure, or relocation;
• limited practical or emotional support;
• medication changes, high stimulant intake, or increasing reliance on alcohol or sedatives;
• heavy or prolonged bleeding, which may coexist with iron deficiency;
• a family history or personal pattern that raises concern for a mood disorder.

The RCPsych position statement emphasises hormonal and wider influences, including physical health, sleep, relationships, work, caring responsibilities, and previous mental illness (RCPsych). The goal is to identify which pressures can be treated or changed.

What can mimic menopausal mental-health symptoms?

There is no single blood test that explains mood, anxiety, sleep, and cognition. A clinician uses the history and examination to decide which medical possibilities need targeted investigation.

Thyroid disease

An overactive thyroid can cause anxiety, irritability, difficulty sleeping, sweating, heat intolerance, palpitations, tremor, weight loss, and reduced sexual interest (NHS). Several of those symptoms resemble menopause or panic. Thyroid testing is useful when the pattern or examination suggests it, not as proof that all midlife distress is hormonal.

Iron deficiency anaemia and other deficiencies

Iron deficiency anaemia may cause fatigue, breathlessness, palpitations, headache, and poor exercise tolerance (NHS). It is especially relevant if periods have become heavy or prolonged. Broad untargeted testing is not always helpful.

Sleep disorders

Loud snoring, witnessed breathing pauses, choking, morning headache, or pronounced daytime sleepiness raises concern for obstructive sleep apnoea. An urge to move the legs that is worse at rest and in the evening suggests restless legs syndrome. These need their own assessment. Treating hot flushes alone will not correct a breathing disorder.

Medicines and substances

Some prescription medicines, over-the-counter decongestants, stimulants, nicotine, alcohol, and changes in regular treatment can affect sleep, mood, heart rate, or concentration. Bring a full list, including herbs, vitamins, and “natural” menopause products. Do not stop a prescribed medicine abruptly based on an online article.

Primary mental-health conditions

A depressive or anxiety disorder can begin at the same age as perimenopause without being caused by it. Trauma symptoms, obsessive thoughts, eating disorders, bipolar-spectrum symptoms, and substance problems also need their own assessment. Timing with cycle change is relevant, but it does not replace diagnostic reasoning.

Other medical or neurological causes

Pain, infection, diabetes, heart rhythm problems, medication toxicity, and neurological disease can alter energy, sleep, mood, or thinking. Sudden confusion, weakness, speech change, collapse, a new severe headache, or loss of consciousness is not “brain fog.” Use urgent medical care.

What a careful assessment should cover

A useful appointment should produce a working explanation, a plan for what to rule out, and clarity about who should manage each part.

Expect questions about:

1. Timing. When did cycles and symptoms change, and do they move together?
2. Function. What has changed in work, study, driving, prayer, relationships, caregiving, or self-care?
3. Mental-health history. Previous depression, anxiety, trauma, severe premenstrual or postpartum symptoms, bipolar symptoms, psychosis, treatment, and family history.
4. Physical symptoms. Bleeding, pelvic symptoms, headaches, weight change, palpitations, heat intolerance, pain, snoring, restless legs, and neurological signs.
5. Medicines and substances. Prescriptions, contraception, supplements, caffeine, nicotine, alcohol, and recent changes.
6. Safety. Thoughts of death or self-harm, inability to stay safe, psychotic symptoms, severe self-neglect, violence, or coercive control.
7. What matters to you. Symptom priorities, fertility and contraception needs, treatment preferences, previous adverse effects, and tolerance for uncertainty or risk.

Do you need hormone blood tests?

For otherwise healthy people aged 45 or over with typical symptoms, NICE recommends identifying perimenopause or menopause without laboratory tests. Menopause can usually be identified in those not using hormonal contraception after at least 12 months without periods, and perimenopause can be identified from new vasomotor symptoms and cycle change (NICE NG23).

FSH testing may be considered in people aged 40 to 45 with menopause symptoms and cycle change, or under 40 when menopause is suspected. Hormonal contraception and some treatments can make bleeding patterns and hormone results harder to interpret. A single “normal” result does not necessarily explain a fluctuating transition.

Other tests depend on the story. A clinician may consider a blood count and iron studies when bleeding is heavy or fatigue is prominent, thyroid tests when thyroid features are present, or other targeted investigation for neurological, cardiac, sleep, or medication concerns. Not everyone needs a large panel.

A useful three-month symptom record

A plain record can reveal more than a one-off hormone result. It is not a diagnostic instrument and needs no score.

For about three months, note:

• the first and last day of bleeding, plus whether flow was unusually heavy or prolonged;
• hot flushes and night sweats, including whether they woke you;
• estimated sleep, awakenings, and how rested you felt;
• low mood, loss of interest, anxiety, panic, irritability, and moments of feeling like yourself;
• one concrete example of a memory or concentration problem;
• headache, pain, palpitations, urinary, or vaginal symptoms;
• major stressors, shift changes, travel, Ramadan schedule changes, illness, or caregiving disruption;
• medicines, supplements, caffeine, and any start, stop, or dose change;
• what the symptom prevented you from doing.

Avoid reducing the record to “good day” or “bad day.” “Woke three times drenched, then missed a deadline because I could not focus” is more useful. Bring the record and your medication list.

What helps?

Treatment should match the main problem. Psychological therapy treats patterns of depression or anxiety; CBT-I treats chronic insomnia; practical measures protect health and recovery; menopause treatment may reduce vasomotor and related symptoms; and medication may be appropriate for a diagnosed mental-health condition. One intervention does not have to carry the whole plan.

Psychological treatment

Structured psychological treatment is appropriate when low mood, anxiety, avoidance, or unhelpful coping patterns persist, whether or not menopause contributed to their onset. Cognitive behavioural therapy, or CBT, works with links among thoughts, emotions, behaviour, and physical symptoms. It can be adapted to depression, anxiety, or menopause-related symptom distress by a suitably qualified professional.

NICE specifically says CBT can be considered for depressive symptoms that do not meet criteria for depression when they are associated with vasomotor symptoms, either alongside or instead of other options (NICE NG23). A diagnosed depressive or anxiety disorder should follow the relevant mental-health guideline, not a shortened “menopause CBT” pathway.

Dr. Dina Rezk Clinic does not provide psychotherapy or mental-health assessment. If these are needed, seek an appropriately qualified mental-health professional. A gynaecology consultation can still address the menopausal or medical contributors in parallel.

Lifestyle measures that support treatment

Lifestyle advice is useful when it is specific and achievable. It is not a cure or a moral test.

• Protect sleep opportunity. Keep wake time reasonably stable, reduce late caffeine if it worsens symptoms, and address night sweats, pain, snoring, or restless legs.
• Move regularly. Choose activity that is safe, repeatable, and realistic in your health context. Movement can support general health, sleep, and mood, but it does not replace treatment for major depression.
• Eat and drink regularly. Long gaps, dehydration, and high caffeine intake can amplify shakiness, headache, and palpitations.
• Reduce alcohol and avoid using sedatives to cope. Alcohol may make sleep feel easier at first while worsening sleep quality and mood later.
• Make recovery visible. Put rest, social contact, and appointments into the calendar.
• Ask for concrete help. “Please handle dinner on Tuesday” is easier to act on than “I need more support.”

If insomnia is the dominant problem, CBT-I is more specific than generic sleep hygiene. See sleep problems in women for the evidence-based distinction.

Treat physical symptoms that are driving distress

If repeated hot flushes are breaking sleep, a menopause treatment discussion may be relevant. If heavy bleeding has contributed to iron deficiency, that needs assessment and treatment. If pain, urinary symptoms, or vaginal symptoms are affecting mood or sleep, name them rather than allowing embarrassment to hide part of the picture.

Genitourinary syndrome of menopause needs its own clinical assessment and is not covered in depth here. Body composition, appearance, and self-image belong in the body image in menopause guide.

MHT and mood: what it can and cannot do

MHT, also called HRT, replaces hormones that decline around menopause. It is an established option for some menopause symptoms, but suitability, formulation, route, dose, and duration require individual assessment.

NICE makes a narrow, useful distinction. It recommends considering HRT to alleviate depressive symptoms that began around the same time as other menopause symptoms when those mood symptoms do not meet criteria for depression (NICE NG23). This is not the same as saying MHT treats major depression, prevents psychiatric illness, or improves mood for everyone.

MHT may help mood indirectly by reducing hot flushes and night waking. If you have diagnosed depression, evidence-based depression care may still be needed. Do not replace prescribed mental-health treatment with MHT without speaking to the clinicians responsible for both plans.

Individualisation and contraindication cautions

MHT decisions are not made from age alone or a generic online checklist. The clinician considers symptoms, whether you have a uterus, bleeding, time since menopause, migraine, cardiovascular and clotting risk, liver health, cancer history, medicines, and preferences. The balance differs by formulation and route (NICE NG23).

Unexplained vaginal bleeding needs assessment before a routine MHT decision. A personal history of a hormone-sensitive cancer, blood clot, stroke, significant cardiovascular disease, or liver disease may change whether MHT is appropriate and which specialist input is needed. These histories do not all carry the same rule, so do not assume either “MHT is forbidden” or “MHT is safe” from a checklist (NICE NG23).

Early menopause, suspected premature ovarian insufficiency, and menopause after surgery or medical treatment have distinct long-term health considerations. They deserve an individual plan rather than advice designed for average-age natural menopause.

NICE recommends referral to a healthcare professional with expertise in menopause when there is uncertainty about the most suitable management option (NICE NG23). The goal is informed choice: expected benefit, uncertainties, risks, alternatives, review, and what would prompt an earlier reassessment.

Do not assume compounded “bioidentical” products, hormone pellets, detoxes, or supplement stacks are safer because they sound natural. Ask whether a product is regulated, what evidence supports it, and who monitors adverse effects.

Medication principles beyond MHT

Medication decisions should follow the condition being treated. A medicine prescribed for depression is not made unnecessary simply because symptoms began during perimenopause. Likewise, an antidepressant should not be started solely because someone has reached menopause.

For diagnosed depression, NICE recommends matching treatment to severity, previous response, preferences, risks, and other health conditions. Antidepressants are not routinely a first-line treatment for less severe depression unless that is the person's informed preference; more severe depression may need a combination of psychological and medication options (NICE NG222).

Some non-hormonal medicines may also be used for selected menopause symptoms, but the choice depends on the target symptom, interactions, adverse effects, and other diagnoses. This page does not recommend an agent, dose, or brand. Medicine availability and licensing in Saudi Arabia do not replace individual prescribing judgement.

Do not stop an antidepressant, anxiety medicine, mood stabiliser, sleeping medicine, or hormone treatment abruptly based on an article. Ask the prescriber about expected benefits, early adverse effects, interaction with other medicines, follow-up, what to do if mood worsens, and how any future reduction would be managed.

Menopause myths that deserve a correction

When a gynaecology consultation is, and is not, the right next step

A gynaecology or women's-health consultation is a reasonable starting point when mood, anxiety, concentration, or sleep changes coincide with:

• changing or unexpectedly absent periods;
• hot flushes or night sweats;
• heavy, prolonged, or irregular bleeding;
• suspected menopause before 45;
• symptoms after gynaecological surgery or treatment;
• questions about contraception, menopause status, or MHT;
• vaginal, urinary, pelvic, or sexual symptoms needing physical assessment.

Such a consultation can review the menstrual and symptom pattern, assess whether menopause is plausible, consider relevant medical mimics, discuss menopause treatment principles, and identify questions that need another specialty.

It is not the complete route when persistent depression, panic, severe anxiety, trauma symptoms, bipolar symptoms, psychosis, substance dependence, an eating disorder, or major cognitive decline is the main problem. Those require assessment by an appropriately qualified mental-health, primary-care, neurological, or other medical service. Both pathways may be appropriate at the same time.

If symptoms are affecting daily life and menopause or gynaecological factors seem central, you can book a women's-health consultation to review those contributors and discuss next steps. No psychological or psychiatric service is implied.

Saudi and Riyadh context

The Saudi Ministry of Health includes post-menopause within its women's-health life-stage information (Saudi MOH Women's Health). This article does not claim a Saudi prevalence figure for menopause-related depression or anxiety because the approved evidence set does not establish one.

Ramadan sleep and meal timing, shift work, long commutes, travel, caregiving, and a busy household may affect symptoms and the practicality of self-care advice. These are circumstances, not explanations about “Saudi women” as a group.

Before an appointment, write down whether privacy, interpreter choice, family involvement, or discussing sexual and urinary symptoms affects what you can say. You can ask a clinic how confidentiality works and whether you may speak to the clinician alone. Do not assume a particular service, professional, or appointment arrangement until the provider confirms it.

For non-emergency medical advice in Saudi Arabia, the Ministry of Health says 937 provides medical consultations through doctors 24 hours a day (MOH 937 Services). For psychological consultation, MOH lists 920033360 and describes the Qareboon app as offering supervised text counselling (MOH and Psychiatric Patient). The cited page does not state current operating hours for 920033360.

Frequently asked questions

The bottom line

Menopause is not a verdict on your mental health. Perimenopause can be a period of increased vulnerability, yet low mood, anxiety, poor sleep, and brain fog are not one interchangeable syndrome. The most useful next step is to identify the dominant problem, its timing, its effect on daily life, and what else could explain it.

Track the pattern for three months if it is safe to wait, bring a full medicine list, and describe concrete examples rather than trying to prove that symptoms are hormonal. A women's-health consultation can assess menopause, bleeding, physical contributors, and MHT suitability. Depression, anxiety disorders, severe insomnia, or cognitive decline may also need their own qualified service.

If symptoms are affecting your daily life and menopausal or gynaecological factors seem central, consider booking a gynaecology consultation to review that part of the picture. If there is immediate danger or you cannot stay safe, use emergency care now.

Sources

1. World Health Organization. Menopause. 16 October 2024. https://www.who.int/news-room/fact-sheets/detail/menopause
2. National Institute for Health and Care Excellence. Menopause: identification and management, NG23. Published 12 November 2015; updated 7 November 2024. https://www.nice.org.uk/guidance/ng23/chapter/recommendations
3. Royal College of Psychiatrists. The menopause and mental health. Position statement PS02/26. 2026. https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/position-statement---ps02-26---menopause.pdf?sfvrsn=bd1f822d_25
4. Badawy Y, Spector A, Li Z, Desai R. The risk of depression in the menopausal stages: A systematic review and meta-analysis. Journal of Affective Disorders. 2024;357:126-133. https://pubmed.ncbi.nlm.nih.gov/38642901/
5. National Institute for Health and Care Excellence. Depression in adults: treatment and management, NG222. 29 June 2022. https://www.nice.org.uk/guidance/ng222/chapter/Recommendations
6. NHS. Overactive thyroid (hyperthyroidism): symptoms. https://www.nhs.uk/conditions/overactive-thyroid-hyperthyroidism/symptoms/
7. NHS. Iron deficiency anaemia. https://www.nhs.uk/conditions/iron-deficiency-anaemia/
8. Ministry of Health, Saudi Arabia. Women's Health. https://www.moh.gov.sa/en/awarenessplateform/womenshealth/pages/default.aspx
9. Ministry of Health, Saudi Arabia. MOH and Psychiatric Patient. https://www.moh.gov.sa/en/ministry/information-and-services/pages/psychiatry.aspx
10. Ministry of Health, Saudi Arabia. Contact Us. https://www.moh.gov.sa/en/ministry/about/pages/contactus.aspx
11. Ministry of Health, Saudi Arabia. 937 Services. https://www.moh.gov.sa/en/937/pages/default.aspx
12. GOV.SA. Emergency Contact Numbers. https://my.gov.sa/en/emergency-contact
13. Saudi Red Crescent Authority. Contact Us. https://www.srca.org.sa/en/contact-us/
14. GOV.SA. Qareboon application service. https://my.gov.sa/ar/services/116567